🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at age 51 after a private battle with pancreatic malignancy.

“The shining star of our family has faded away for us in the present world,” his relatives stated. “After a lengthy and brave struggle with cancer, we are deeply saddened to declare that Michael D’Angelo Archer, recognized by his fans around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on the music industry with his innovative neo-soul sound and collaborations with high-profile artists.

He released his first record, “Brown Sugar,” in the mid-nineties to instant praise. The record reached No. 4 on the R&B charts, earned platinum status soon after, and earned several Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his artistic journey into the limelight. The album premiered at the top spot on both Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a hesitant one, in the public consciousness. The intimate portrayal featured the artist, notably stripped down to his waist, performing directly into the camera.

D’Angelo retreated from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe car crash that left him in critical condition.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with a further top chart entry on the soul music rankings and a award for Best R&B Album.

Once more, in his own enigmatic way, D’Angelo had limited public outings in the following years.

The singer was scheduled as a top act for the 2025 Roots Picnic festival, but his performance was canceled, citing an “unexpected health issue.”

Even though information is limited about D’Angelo’s health in the weeks before his passing, he had reportedly been in the hospital for months and in palliative care for a fortnight.

D’Angelo’s passing is a clear example of the harmful impact of pancreatic cancer, one of the deadliest and least preventable types of the disease, on a gifted artist whose life was ended too soon.

“We are grieved that he can only provide cherished moments with his loved ones, but we are forever thankful for the legacy of extraordinarily moving songs he has left us,” his family said.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the pancreas, a small organ that produces insulin and plays an essential role in digestion, among other functions. The size and location of the organ in the human system make it more difficult to detect malignancy.

Even though pancreatic cancer accounts for only approximately three percent of malignancy cases each year in the United States, it is causes seven percent of cancer deaths.

Nearly 70,000 individuals will be found to have pancreatic cancer and about 52,000 will succumb to the disease in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have few and poor therapies, and a narrow opportunity to make a meaningful impact on the lives of people,” said a cancer specialist.

Since pancreatic cancer seldom produces initial signs, it’s frequently diagnosed only once the disease is advanced. Even when a patient has symptoms they are usually nonspecific and may be mistaken for a number of everyday ailments.

“Currently, there is no good way to identify this malignancy in the initial phases, apart from listening to your body and consulting your doctor if there are unfamiliar symptoms,” said a medical director.

Common symptoms of this disease include:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• reduced hunger
• brownish urine
• light-colored or greasy stools
• diarrhea
• increased appetite or thirst
• nausea

At age 51, D’Angelo’s death is an exception, as pancreatic cancer is typically found in adults in the sixty-five to seventy-five age bracket. However, many cancers, including pancreatic cancer, have become more common among younger adults.

“This disease diagnosed prior to fifty is deemed uncommon, yet concerningly, doctors are beginning to see a rising count of younger individuals affected by this condition,” commented a expert.

Family History Affects Disease Probability

Without reliable detection methods for pancreatic cancer, professionals stressed the importance of knowing your family’s cancer history. Certain risk factors, such as smoking and excess weight also play a role in the development of pancreatic cancer.

African Americans have the highest incidence of pancreatic cancer in the U.S. and are more prone to be diagnosed with inoperable cancer.

“The initial action toward lowering one’s chance of this condition is understanding individual susceptibility. Individuals should examine their family history, genetic background, and medical conditions, such as diabetes, long-term pancreas inflammation, or overweight that may increase their susceptibility,” said a specialist.

Inherited genetic risk factors are linked to as much as ten percent of all this malignancy cases. If someone in your family has had pancreatic cancer, you may want to think about DNA analysis.

“For individuals with a relative’s background of pancreatic cancer or those having high risk genetic mutations, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect early changes in the organ,” he clarified.

For those wishing to lower their chance, lifestyle changes may have an effect. The best action you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy drinking is associated with pancreatitis, a risk factor for pancreatic cancer, so reducing or avoiding drinks may help lower your chance.

Managing your weight or losing weight may also aid reduce your risk. People with obesity are 20% more likely to develop this disease. This malignancy also occurs more often in those with blood sugar issues, and weight loss can also reduce the chance of type 2 diabetes.

In spite of this disease’s poor prognosis, there is still hope.

“We are doing better with treatments and more recent combination chemotherapy. There are developing precision medicines that already are making an impact,” said a specialist.

For many individuals, however, awareness about this uncommon but {dev